Akèy › Skleroz an milti pwogresif kwonik › Kalifòni
Etid klinik pou Skleroz an milti pwogresif kwonik nan Kalifòni
10 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Fullerton Neurology and Headache Center, Fullerton
- Harbor-UCLA Medical Center - The Lundquist Institute (Los Angeles Biomedical Research Institute (LA BioMed)), Torrance
- Regina Berkovich MD, PhD Inc, West Hollywood
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 30, 2026 · NCT07299019A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Regina Berkovich MD, PhD Inc., West Hollywood
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 22, 2026 · NCT07067463Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- UC San Diego, La Jolla
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07477639Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Stanford Multiple Sclerosis Center, Palo Alto
Ap rekriteFaz 3
Laj 18 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT04047628A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Fullerton Neuro and Headache Ctr, Fullerton
- Regina Berkovich MD PhD Inc, West Hollywood
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
- Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco
Ap rekriteFaz 1/2
Laj 18 a 55 · Tout sèks · Mizajou Jul 2, 2026 · NCT05359653Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
- Stanford University, Redwood City
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou Mar 23, 2026 · NCT07139743A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
- Stanford Multiple Sclerosis Center, Palo Alto
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Feb 27, 2026 · NCT06138132"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
- University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Oct 31, 2025 · NCT07222618MS-ResearchBiomarkerS
- Cedars-Sinai Medical Center, Los Angeles
Ap rekriteEtid obsèvasyonVolontè an sante akeyiMande peman pou patisipan yo
Laj 18 ak plis · Tout sèks · Mizajou Feb 6, 2024 · NCT05204459Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.